Autologous Peripheral Blood Stem Cell Transplantation With In Vivo Purging as an Alternate Stem Cell Transplantation Program for Pts w/AML in 1st & 2nd Complete Remission w/no HLA Matched Related Donor

Not Applicable

Completed

• Conditions: Leukemia, Monocytic, Acute

• Registration Number: NCT00531583
• Lead Sponsor: King Faisal Specialist Hospital & Research Center

Brief Summary

Autologous peripheral Bld Stem Cell Transplantation with In Vivo Purging as an alternate stem cell transplantation program for pts w/AML in 1st \& 2nd complete remission w/no HLA matched related donor

Detailed Description

Not available

Study Timeline

• Study Start: 2001-03
• Study First Submitted: 2007-09-17
• Study First Submitted QC: 2007-09-18
• Study First Posted: 2007-09-19
• Primary Completion: 2015-06
• Study Completion: 2015-06
• Status Verified: 2016-01
• Last Update Submitted: 2016-01-04
• Last Update Posted: 2016-01-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 350

Inclusion Criteria

• Patients with AML in 1st & 2nd complete remission w/no HLA matched related donor

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Efficacy	2009-2015

Trial Locations

Locations (1)

KFSH&RC; 🇸🇦 Riyadh, Saudi Arabia